BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 14558920)

  • 1. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
    Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F
    Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA.
    Takano T; Miyauchi A; Yokozawa T; Matsuzuka F; Maeda I; Kuma K; Amino N
    Cancer Res; 1999 Sep; 59(18):4542-5. PubMed ID: 10493503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular classification of thyroid nodules by cytology.
    Pagedar NA; Chen DH; Wasman JK; Savvides P; Schluchter MD; Wilhelm SM; Lavertu P
    Laryngoscope; 2008 Apr; 118(4):692-6. PubMed ID: 18094649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients.
    Vendittelli F; Raffaelli M; Fadda G; Carelli-Alinovi C; Paolillo C; Bellantone R; Zuppi C; Capoluongo E
    Clin Chem Lab Med; 2012 Jan; 50(4):715-20. PubMed ID: 22505562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
    Bernet VJ; Anderson J; Vaishnav Y; Solomon B; Adair CF; Saji M; Burman KD; Burch HB; Ringel MD
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4792-6. PubMed ID: 12364475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction.
    Higashiyama T; Takano T; Matsuzuka F; Liu G; Miyauchi A; Yokozawa T; Morita S; Kuma K; Shiba E; Noguchi S; Amino N
    Thyroid; 1999 Mar; 9(3):235-40. PubMed ID: 10211598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
    Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
    Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules.
    Siddiqui MT; Greene KL; Clark DP; Xydas S; Udelsman R; Smallridge RC; Zeiger MA; Saji M
    Diagn Mol Pathol; 2001 Jun; 10(2):123-9. PubMed ID: 11385322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of oncofetal fibronectin mRNA in thyroid anaplastic carcinoma.
    Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
    Jpn J Clin Oncol; 2007 Sep; 37(9):647-51. PubMed ID: 17704536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules.
    Aratake Y; Umeki K; Kiyoyama K; Hinoura Y; Sato S; Ohno A; Kuribayashi T; Hirai K; Nabeshima K; Kotani T
    Diagn Cytopathol; 2002 Jun; 26(6):366-72. PubMed ID: 12112826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents.
    Niedziela M; Maceluch J; Korman E
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4411-5. PubMed ID: 12213909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates.
    Patel MR; Stadler ME; Deal AM; Kim HS; Shores CG; Zanation AM
    Laryngoscope; 2011 May; 121(5):983-9. PubMed ID: 21520112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitous expression of galectin-3 mRNA in benign and malignant thyroid tumors.
    Takano T; Miyauchi A; Matsuzuka F; Yoshida H; Kuma K; Amino N
    Cancer Lett; 2003 Sep; 199(1):69-73. PubMed ID: 12963125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
    Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
    Hesse E; Musholt PB; Potter E; Petrich T; Wehmeier M; von Wasielewski R; Lichtinghagen R; Musholt TJ
    Br J Cancer; 2005 Sep; 93(5):565-70. PubMed ID: 16091757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR.
    Samija I; Mateša N; Lukač J; Kusić Z
    Diagn Mol Pathol; 2011 Dec; 20(4):233-41. PubMed ID: 22089351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
    Liou MJ; Chan EC; Lin JD; Liu FH; Chao TC
    Cancer Lett; 2003 Mar; 191(2):223-7. PubMed ID: 12618337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.